Coeliac UK’s Director of Policy, Research & Campaigns, Norma McGough, welcomes NICE’s new quality standards on coeliac disease, which she believes will bring clarity and improvement to diagnosis screening and better access to long term treatment…
On the 19th October 2016, the National Institute of Health and Care Excellence (NICE) published the first quality standard on coeliac disease.[1] This standard is underpinned by the NICE guideline that was published last year and encompasses recognition, assessment and management of coeliac disease.[2]
This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.
Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.
What you’ll discover:
Key trends shaping the pharmaceutical formulation sector
Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
Can’t attend live? No worries – register to receive the recording post-event.
The new standard sets out five key areas to drive measurable improvements in care of patients with coeliac disease in recognition, diagnosis, support and health for adults and children. This is key as in the context of current rationalisation of resource within the NHS, there is a real risk that management of coeliac disease may become marginalised, as it is a disease that to all intents and purposes is ‘self-managed.’ The Health & Social Care Act 2012 sets out a clear expectation that the care system should consider NICE quality standards in planning and delivering services[3].
“there is a real risk that management of coeliac disease may become marginalised”
With only 24% of the 1 in 100 currently diagnosed in UK we still have a long way to go to raise awareness within healthcare settings, in particular primary care and also with the general public, in order to identify the remaining 500,000 people with the disease.[4]
Benefits of early recognition
The benefits of early recognition are well documented but the presentation of coeliac disease produces notable challenges for healthcare professionals with its changing face and wide range of symptoms.
Dr Geraint Preest shares his tips for GPs diagnosing coeliac disease, highlighting the prevalence of the autoimmune condition. Source: Coeliac UK
Misdiagnosed as Irritable Bowel Syndrome
Despite having NICE guidance providing a framework for recognition of coeliac disease for the last seven years, patients continue to be misdiagnosed with Irritable Bowel Syndrome (IBS), instead of being first tested for coeliac disease.[5]
Clear targets for screening
We therefore welcome the new quality standard, providing clear targets, for screening at risk groups of patients, including patients with IBS and for providing a standard timeline for having endoscopy to confirm diagnosis.
Delays in referral for endoscopy after positive serological testing can have a detrimental impact on the outcome of the process. This is because it is essential that patients continue to eat a gluten-containing diet throughout the two-step process for diagnosis.
It may seem simple enough but without this requirement being fulfilled, investigations are a waste of time.
Gluten-free diet as medical treatment
As the gluten-free diet is the medical treatment for coeliac disease it is imperative that gluten is not removed from the diet until a confirmed diagnosis has been made, otherwise the clinical markers used to identify the disease may disappear and the test results may be inaccurate.
If people are symptomatic and the time to endoscopy is prolonged they may be tempted to cut gluten out of their diet to relieve their symptoms. Accurate dietary information is necessary both before, during and after diagnosis of coeliac disease.
Sticking to a gluten free diet is the treatment for Coeliac disease
With reference to dietary management, NICE highlights the importance of referral to a healthcare professional with specialist knowledge of coeliac disease to discuss how to follow a gluten-free diet. The rationale underpinning this recommendation is that it is important for patients with coeliac disease to manage their gluten-free diets, the treatment for coeliac disease, in order to avoid continuing ill health.
High cost of gluten free products
The NICE quality standard also highlights the inequality arising from the higher cost of gluten-free products and the limited availability in small retail outlets. To address this healthcare professionals should help people who may need support find suitable gluten-free foods on prescription.
Annual reviews
The new NICE standard references the importance of offering annual review to patients with coeliac disease and highlights the need for local approaches to encourage as many people as possible to attend with particular reference to socioeconomically deprived areas where people are less likely to attend.
This is an important development as coeliac disease is a treatable disease which requires significant knowledge transfer, lifestyle change and ongoing support to maintain the gluten-free diet treatment and to review patients to screen for preventable long-term complications of the disease.
Check out Coeliac UK’s first ever television advert which hopes to find the half a million people in the UK who are living with coeliac disease without knowing it. Source: Coeliac UK
About the author
Norma McGough began her career as a registered dietitian in the Health Service. In the last 20 years she has worked in the voluntary sector, managing teams at both Diabetes UK and Coeliac UK. Norma currently heads the Policy, Research & Campaigns team and as a member of the senior management team, her role is pivotal in the strategic development of the Charity’s knowledge base.
References
1] National Institute of Health & Clinical Excellence (NICE) 2016 quality standard on coeliac disease (QS 134) https://www.nice.org.uk/guidance/QS134
2] National Institute of Health & Clinical Excellence (NICE) 2015 recognition, assessment and management of coeliac disease (NG20) https://www.nice.org.uk/guidance/ng20
4] West et al 2014 Incidence and prevalence of coeliac disease and dermatitis herpetiformis in the UK over two decades: population based study. Am Journ Gastroenterol 109(5): 757–768
5] National Institute of Health & Clinical Excellence (NICE) 2009recognition and assessment of coeliac disease https://www.nice.org.uk/guidance/CG86
This website uses cookies to enable, optimise and analyse site operations, as well as to provide personalised content and allow you to connect to social media. By clicking "I agree" you consent to the use of cookies for non-essential functions and the related processing of personal data. You can adjust your cookie and associated data processing preferences at any time via our "Cookie Settings". Please view our Cookie Policy to learn more about the use of cookies on our website.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as ”Necessary” are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies “Advertising & Targeting”, “Analytics” and “Performance”, these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to ‘Enabled’ or ‘Disabled’, then click ‘Save and Accept’. View our Cookie Policy page.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Cookie
Description
cookielawinfo-checkbox-advertising-targeting
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance
This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID
This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged
This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.
Performance cookies are includes cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.
Cookie
Description
cf_ob_info
This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob
This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only
This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush
This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db
This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC
This cookie is set by Youtube and is used to track the views of embedded videos.
Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.
Cookie
Description
bcookie
This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS
This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang
This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc
This cookie is set by LinkedIn and used for routing.
lissc
This cookie is set by LinkedIn share Buttons and ad tags.
vuid
We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId
This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule
This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session
This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues
This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga
This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat
This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid
This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.
Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.
Cookie
Description
advanced_ads_browser_width
This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions
This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info
This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer
This cookie is set by Advanced Ads and sets the referrer URL.
bscookie
This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE
This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr
This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory
This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE
This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.